MPLT logo

MPLT
MapLight Therapeutics Inc.

91
Mkt Cap
$1.13B
Volume
437,082.00
52W High
$30.28
52W Low
$12.24
PE Ratio
-7.20
MPLT Fundamentals
Price
$26.73
Prev Close
$29.41
Open
$29.51
50D MA
$18.81
Beta
2.07
Avg. Volume
228,140.10
EPS (Annual)
-$3.66
P/B
2.57
Rev/Employee
$0.00
$473.98
Loading...
Loading...

About

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
133

Frequently Asked Questions

What is Market Cap of MapLight Therapeutics Inc.?
What is the 52-week high for MapLight Therapeutics Inc.?
What is the 52-week low for MapLight Therapeutics Inc.?
What is MapLight Therapeutics Inc. stock price today?
What was MapLight Therapeutics Inc. stock price yesterday?
What is the PE ratio of MapLight Therapeutics Inc.?
What is the Price-to-Book ratio of MapLight Therapeutics Inc.?
What is the 50-day moving average of MapLight Therapeutics Inc.?
How many employees does MapLight Therapeutics Inc. have?

Latest MPLT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.